Erudio Healtherudio.com
Drug
TQB2102 trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying TQB2102: APEX-Breast01. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| APEX-Breast01 NCT06561607 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | HER2 low-expressing recurrent/metastatic breast cancer | Phase 3 | 40 | 12 | Focused | Nov 4, 2026 | Preview |